Most Read Articles
27 Aug 2018
Foetal exposure to quetiapine during the first trimester does not appear to increase the risk of major malformations in infants, according to a study.
Stephen Padilla, 13 Oct 2020
Tocilizumab is a common treatment for rheumatoid arthritis (RA) patients with comorbid conditions or obesity and is effective irrespective of comorbidity burden or obesity status, according to a study.
15 Jun 2018
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.
Pearl Toh, 08 Jul 2020
The investigational JAK1* inhibitor filgotinib was noninferior to adalimumab in reducing disease activity in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate response to methotrexate (MTX-IR), according to the FINCH 1 study presented at EULAR 2020 Virtual Meeting.

Product Highlight - Dupixent

16 Sep 2020
First and Only Biologic Therapy that specifically targets IL-4 and IL-13, key drivers of persistent underlying Type 2 inflammation (including Atopic Dermatitis and Asthma)1,2

Now locally approved for:

- Adult & adolescent (aged 12-17) patients with moderate-to-severe atopic dermatitis who are candidates for systemic therapy1
- An add-on maintenance treatment for patients (12+ years) with inadequately controlled severe asthma with type 2 inflammation1


References:
1. DUPIXENT Summary of Product Characteristics. May 2020.
2. Gandhi NA et al. Nature Rev Drug Disc 2016; 15: 35–50.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
27 Aug 2018
Foetal exposure to quetiapine during the first trimester does not appear to increase the risk of major malformations in infants, according to a study.
Stephen Padilla, 13 Oct 2020
Tocilizumab is a common treatment for rheumatoid arthritis (RA) patients with comorbid conditions or obesity and is effective irrespective of comorbidity burden or obesity status, according to a study.
15 Jun 2018
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.
Pearl Toh, 08 Jul 2020
The investigational JAK1* inhibitor filgotinib was noninferior to adalimumab in reducing disease activity in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate response to methotrexate (MTX-IR), according to the FINCH 1 study presented at EULAR 2020 Virtual Meeting.